Redefining Pain Care: Why Access to Opioids Is a Healthcare Imperative

Redefining Pain Care: Why Access to Opioids Is a Healthcare Imperative

OPOS CEO and Founder Justin Kromelow shares an evidence-backed perspective on the opioid crisis—and the patients being left behind. With 25 million Americans relying on long-term opioid therapy to maintain independence and quality of life, Kromelow explains why blanket restrictions have created a second crisis: a collapse in access for those who need it most.

Justin walks through a smarter, safer model for opioid management—one that empowers providers with regulatory support, elevates patient function over pain scores, and restores profitability to practices while dramatically improving outcomes. He also opens up about OPOS’s rapid growth and his mission to rewrite the standard of care.

• The opioid epidemic has overshadowed the legitimate, often critical role of opioids for millions with chronic pain.
• Restrictive prescribing rules and outdated insurance policies have reduced access and driven patients to unsafe alternatives.
• OPOS’s model focuses on risk-managed care, patient education, and data-driven treatment, enabling providers to safely prescribe and improve quality of life.
• A group-based care model not only reduces stigma but improves access, compliance, and profitability.
• The system aligns incentives for all stakeholders—patients, providers, payers—while reducing ER visits and unnecessary procedures.
• Through national expansion and strategic partnerships, OPOS has driven 7–8x ARR growth—empowering pain practices to deliver better outcomes with a guaranteed return on investment.